Cantor Fitzgerald Upgrades Galena Biopharma (GALE) to Hold
Tweet
Share
E-mail
Get Alerts GALE Hot Sheet
Price: $0.21 --0%
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 53
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 53
Join SI Premium – FREE
Cantor Fitzgerald upgraded Galena Biopharma (NASDAQ: GALE) from Sell to Hold with a price target of $2.00 (unchanged).
For an analyst ratings summary and ratings history on Galena Biopharma click here. For more ratings news on Galena Biopharma click here.
Shares of Galena Biopharma closed at $1.52 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Upgrades Omeros Corp. (OMER) to Overweight, 'We May Have Underestimated Yartemlea'
- Okta, Inc (OKTA) PT Raised to $235 at DA Davidson Following Oktane 2026
- JPMorgan Upgrades CoreWeave (CRWV) to Overweight, 'Setting Up for Share Price Upsides'
Create E-mail Alert Related Categories
UpgradesRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
